These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD. Bunke M, Bartlett DK, Brier ME, Golper TA. Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957 [Abstract] [Full Text] [Related]
5. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis]. Zelichowski G, Lubas A, Sienkiewicz M, Janusz E, Wańkowicz Z. Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362 [Abstract] [Full Text] [Related]
6. Treatment of the anemia with human recombinant erythropoietin in CAPD patients. Miranda B, Selgas R, Riñon C, Fernandez-Zamorano A, Borrego F, Ortuño F, Lopez-Revuelta K, Torre A, Sanchez Sicilia L. Adv Perit Dial; 1990 Apr; 6():296-301. PubMed ID: 1982831 [Abstract] [Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin. Salmonson T. Scand J Urol Nephrol Suppl; 1990 Apr; 129():1-66. PubMed ID: 2255869 [Abstract] [Full Text] [Related]
11. The effect of recombinant human erythropoietin (r-Hu EPO) administration on the blood chemistries and composition in uremic rats. Kozioł M, Ksiazek P, Feldo M, Spasiewicz D, Michalak J, Kleinrok Z. Ann Univ Mariae Curie Sklodowska Med; 1994 Apr; 48 Suppl 3():61-6. PubMed ID: 8192533 [Abstract] [Full Text] [Related]
12. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity. Bajo MA, Selgas R, Miranda B, Fernandez-Zamorano A, Borrego F, Romero JR, Caparros G, Riñon C, Sanchez Sicilia L. Adv Perit Dial; 1991 Apr; 7():296-300. PubMed ID: 1680450 [Abstract] [Full Text] [Related]
13. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis. Uthayanaka Y, Jirajan B, Krairithichai U, Jantavanich N. Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072 [Abstract] [Full Text] [Related]
16. [Effect of recombinant human erythropoietin (rHu-EPO) on anemia and selected biochemical parameters in patients in the pre-dialysis period]. Sułowicz W, Drozdz M, Hanicki Z, Kraśniak A, Kuźniewski M. Przegl Lek; 1992 Sep; 49(1-2):50-3. PubMed ID: 1455007 [Abstract] [Full Text] [Related]
19. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin. Boran M, Dalva I, Yazicioğlu A, Akbay E, Cetin S. Int Urol Nephrol; 1993 Sep; 25(2):197-203. PubMed ID: 8365853 [Abstract] [Full Text] [Related]
20. [Maintenance therapy on the anemia in continuous ambulatory peritoneal dialysis (CAPD) patients using subcutaneous administration of recombinant human erythropoietin fortnightly--a multicenter trial]. Kubota M, Kawaguchi Y, Nomoto Y, Tsuchida H, Nihei H, Kubo K, Omori Y, Babazono T, Ogura Y, Hara S. Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1081-90. PubMed ID: 8230819 [Abstract] [Full Text] [Related] Page: [Next] [New Search]